Kangtai Biological Products Co. Ltd.
No. 6, Road Kefa, Nantou Science & Industry Park
Shenzhen
518057
China
Tel: 86-755-26988688
Fax: 86-755-26988600
Website: http://www.biokangtai.com/
Email: office@biokangtai.com
About Kangtai Biological Products Co. Ltd.
Shenzhen Kangtai Biological Products Co., Ltd. discovers, develops, manufactures, and markets biological products in China. It manufactures hepatitis B vaccine that prevents liver cancer. The company distributes its products in 31 provinces. Shenzhen Kangtai Biological Products Co., Ltd. was founded in 1992 and is based in Shenzhen, China.YEAR FOUNDED:
1992
4 articles about Kangtai Biological Products Co. Ltd.
-
Licensing and Agency Agreement Signed between Beijing Minhai (Biokangtai) and Phil. Pharmawealth, Inc.
8/31/2022
Beijing Minhai Biotechnology Co., Ltd. held a signing ceremony with Phil. Pharmawealth, Inc. for their cooperation in jointly promoting the registration, promotion, distribution, marketing, and sales of Beijing Minhai's 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine in the Philippines.
-
Biokangtai: Recombinant COVID-19 Vaccine(Adenovirus Vector) licensed for manufacturing, which actively promotes vaccine export and improves vaccine accessibility
9/9/2021
The other day Shenzhen Kangtai Biological Products Co., Ltd. announced that the company and AstraZeneca signed the "Amendment 1 to License Agreement".
-
BIOKANGTAI COVID-19 Vaccine Approved for Phase III Clinical Trial in the Philippines
8/2/2021
On July 30, Shenzhen Kangtai Biological Products Co., Ltd. was approved by the Philippine Food and Drug Administration to launch the phase III clinical trial of its independently developed Inactivated COVID-19 Vaccine in the local area.
-
Kangtai Biological Products Co. Ltd.'s Stock Price Rises 12-Fold Following Shenzhen IPO
3/17/2017